Skip to main content Back to Top
Advertisement

6/27/2017

Tetracaine Hydrochloride Ophthalmic Drops

Reason for the Shortage

    • Altaire has tetracaine ophthalmic drops available.
    • Novartis has tetracaine ophthalmic drops available.
    • Ocusoft has Tetravisc and Tetravisc Forte available.
    • Valeant has tetracaine ophthalmic drops available.

Available Products

    • Altacaine ophthalmic drops, Altaire, 0.5%, 15 mL bottle, 1 count, NDC 59390-0181-13
    • Tetravisc ophthalmic drops, OCuSOFT, 0.5%, 0.6 mL unit-dose container, 12 count, NDC 54799-0505-01
    • Tetravisc ophthalmic drops, OCuSOFT, 0.5%, 5 mL bottle, 1 count, NDC 54799-0505-05
    • Tetravisc Forte ophthalmic drops, OCuSOFT, 0.5%, 0.6 mL unit-dose container, 12 count, NDC 54799-0504-01
    • Tetravisc Forte ophthalmic drops, OCuSOFT, 0.5%, 5 mL bottle, 1 count, NDC 54799-0504-05
    • Tetracaine ophthalmic drops, Novartis, 0.5%, 4 mL bottle, 1 count, NDC 00065-0741-14
    • Tetracaine ophthalmic drops, Valeant, 0.5%, 15 mL bottle, 1 count, NDC 24208-0920-64

Updated

Updated June 27, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 7, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.